 |
Pfizer shares plung after the company announces its arthritis drug Celebrex posed "increased cardiovascular risk" when used in high doses. Celebrex is a COX-2 inhibitor drug similar to Vioxx, which Merck withdrew from the market in September over similar health issues. |
|